Dudediligence.

NovaBridge Biosciences

NBPNASDAQ
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$647,966

6 notices · 186,889 sh

Oct 2025 to Oct 2026

Reported ·

$61,956

3 sales · 1 buy · $577,300 bought

Oct 2025 to Jun 2026

The two figures cover different periods.

None of the 3 reported sales carry the 10b5-1 box. Together they are 0.01% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-18: Dennis Phillip Andrew, Form 1442026-09-09: Cao Sean Wuxiong, Form 1442026-05-14: Cao Sean Wuxiong, Form 1442026-03-18: Dennis Phillip Andrew, Form 1442026-01-02: Skelton Joseph W., Form 1442025-12-18: Dennis Phillip Andrew, Form 1442026-04-24: Hagler Mark Arnold, bought2026-05-14: Cao Sean Wuxiong, sold2026-06-01: Xu Cong Claire, sold2026-06-18: Dennis Phillip Andrew, sold
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-09-18Dennis Phillip Andrew, Chief Medical Officer$5,799
3,569 shno plan dateForm 4s on file end Jun 23144 ↗
2026-09-09Cao Sean Wuxiong, Chief Bus. Development Officer$79,378
46,947 shno plan dateForm 4s on file end Jun 23144 ↗
2026-05-14Cao Sean Wuxiong, Chief Bus. Development Officer$18,534
9,304 shno plan date144 ↗
Form 4, 2026-05-18: sold 21,399 at $1.99 Form 4 ↗
2026-03-18Dennis Phillip Andrew, Chief Medical Officer$10,153
3,638 shno plan dateno Form 4 on file144 ↗
2026-01-02Skelton Joseph W., Officer, FORMER CFO$519,600
120,000 shplan 2025-09-12no Form 4 on file144 ↗
2025-12-18Dennis Phillip Andrew, Chief Medical Officer$14,501
3,431 shno plan dateno Form 4 on file144 ↗